Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHAMAB-B

5.980
-0.070-1.16%
Volume:4.06M
Turnover:24.38M
Market Cap:5.75B
PE:-25.41
High:6.160
Open:6.120
Low:5.910
Close:6.050
Loading ...

Alphamab Oncology to Turn to 2024 Profit

MT Newswires Live
·
Yesterday

BUZZ-HK-listed Alphamab Oncology jumps on expectation of first annual profit

Reuters
·
Yesterday

BRIEF-Alphamab Oncology Sees Profit Of Not Less Than RMB150.0 Million For Year

Reuters
·
04 Mar

Alphamab Oncology - Expected Result Due to Three License Collaborations and Sales Revenue in FY

THOMSON REUTERS
·
04 Mar

Alphamab Oncology Sees Profit of Not Less Than RMB150.0 Mln for Year

THOMSON REUTERS
·
04 Mar

Market Participants Recognise Alphamab Oncology's (HKG:9966) Revenues Pushing Shares 88% Higher

Simply Wall St.
·
28 Feb

Even after rising 14% this past week, Alphamab Oncology (HKG:9966) shareholders are still down 78% over the past five years

Simply Wall St.
·
11 Feb

BRIEF-Alphamab Oncology Receives Approval From CDE China For JSKN003 To Initiate Phase III Clinical Study

Reuters
·
27 Dec 2024

Alphamab Oncology's Anti-Tumor Drug Gets NMPA's Nod for Phase III Clinical Trials

MT Newswires Live
·
27 Dec 2024

Alphamab Oncology - Approval From Cde China for Jskn003 to Initiate a Phase Iii- Clinical Study for Treatment of Oc

THOMSON REUTERS
·
27 Dec 2024

Alphamab Oncology's Anti-Tumor Drug Gets IND Approval from NMPA

MT Newswires Live
·
26 Dec 2024

Breakeven On The Horizon For Alphamab Oncology (HKG:9966)

Simply Wall St.
·
17 Dec 2024

Alphamab Oncology Presents Clinical Study Results for Tumor Treatment at Houston Cancer Meet

MT Newswires Live
·
11 Nov 2024

Alphamab Oncology Receives Waivers for Company Secretary from Hong Kong Bourse

MT Newswires Live
·
29 Oct 2024

Hong Kong Stocks Surge as China's Property Sector Rescue Overshadows Weak PMI Data

MT Newswires Live
·
30 Sep 2024

Alphamab Oncology's Unit Signs Licensing Agreement for Tumor Drug; Alphamab Shares Surge 39%

MT Newswires Live
·
30 Sep 2024